(Sharecast News) - Wizz Air: HSBC downgrades to 'reduce' and lowers target price from 4,500.0p to 4,100.0p; JP Morgan keeps at 'overweight' and marks up target from 5,350.0p to 5,800.0p.
Pennon: HSBC downgrades to 'reduce' with target price of 1,160.0.
UDG: Barclays downgrades to 'equalweight' with 1,080.0p target price.
Rio Tinto: JP Morgan stays at 'overweight' but lowers target from 8,250.0p to 7,770.0p.
Man Group: Barclays stays at 'equalweight' and hikes target price from 170.0p to 210.0p.
Victrex: Barclays keeps at 'equalweight' and raises target price from 1,870.0p to 2,150.0p.
Metro Bank: Barclays stays at 'underweight' with target price unchanged at 115.0p.
Pets at Home: Peel Hunt downgrades from 'buy' to 'add' with target price of 525.0p.
Fresnillo: BMO upgrades to 'outperform' with a target price of 1,100.0p.
Mitchells & Butlers: Peel Hunt upgrades from 'hold' to 'buy' with a target price of 335.0p.
Croda: Liberum reiterates 'buy' and lifts target price from 7,400.0p to 9,200.0p.
Barclays: JP Morgan keeps at 'buy' and raises target price from 230.0p to 240.0p; Deutsche Bank stays at 'buy' and raises target from 230.0p to 240.0p.
Melrose: Citi reinstates coverage with a 'buy' recommendation and sets target price of 185.0p.
Mirriad Advertising: Canaccord Genuity keeps at 'speculative buy' but cuts target price from 58.0p to 44.0p.
National Express Group: Berenberg keeps at 'buy' but lowers target price from 370.0p to 340.0p.
AstraZeneca: ShoreCap reiterates 'buy'
Lloyds Banking Group: ShoreCap reiterates 'buy'
12 May 2021 07:33
Private equity firm to buy UDG Healthcare
LONDON, May 12 (Reuters) - Private equity firm Clayton, Dubilier & Rice (CDR) has agreed to buy London-listed UDG Healthcare for 2.6 billion pounds ($3.7 billion), the pharmaceuticals services company said on Wednesday.CDR has agreed to pay 10.23 ...
Read more